World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
73
Citations
20935
World Ranking
2127
National Ranking
1034

Overview

Carol O. Tacket is affiliated with the University of Maryland, Baltimore in the United States. Their academic profile does not currently include any listed recent papers, frequent co-authors, or specific publication venues. Likewise, no specific book publications or awards have been documented.

Although detailed information about their research topics, fields of study, or subfields is not provided, their association with a major research university suggests involvement in scholarly activities within their institutional environment.

Available data does not specify any main topics of work or areas of expertise, nor are there records of notable collaborative relationships or publication patterns in leading academic venues.

The absence of published papers in the immediate data indicates either emerging research activities or a focus on roles beyond documented publication, such as teaching, administration, or practice within their discipline.

Best Publications

  • Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato.

    Carol O. Tacket;Hugh S. Mason;Genevieve Losonsky;John D. Clements

  • HUMAN IMMUNE RESPONSES TO A NOVEL NORWALK VIRUS VACCINE DELIVERED IN TRANSGENIC POTATOES

    Carol O. Tacket;Hugh S. Mason;Genevieve Losonsky;Mary K. Estes

  • Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers.

    James P. Nataro;Deng Yikang;Susan Cookson;Alejandro Cravioto

  • Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli.

    Carol O. Tacket;Genevieve Losonsky;Harriet Link;Yen Hoang

  • Clinical Features and an Epidemiological Study of Vibrio vulnificus Infections

    Carol O. Tacket;Frances Brenner;Paul A. Blake

  • Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218

    R Edelman;C O Tacket;S S Wasserman;S A Bodison

  • Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection.

    M S Donnenberg;C O Tacket;S P James;G Losonsky

  • Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.

    MyronM. Levine;Deirdre Herrington;Genevieve Losonsky;Ben Tall

  • Clinical responses to undiluted and diluted smallpox vaccine.

    Sharon E. Frey;Robert B. Couch;Carol O. Tacket;John J. Treanor

  • Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers.

    C O Tacket;D M Hone;rd R Curtiss;S M Kelly

  • Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans.

    Carol O. Tacket;Marcelo B. Sztein;Genevieve A. Losonsky;Steven S. Wasserman

  • Adjuvanted Intranasal Norwalk Virus-Like Particle Vaccine Elicits Antibodies and Antibody-Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues

    Samer S. El-Kamary;Marcela F. Pasetti;Paul M. Mendelman;Sharon E. Frey

  • Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers.

    Carol O Tacket;Marcelo B Sztein;Genevieve A Losonsky;Steven S Wasserman

  • A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells.

    H Karch;J Heesemann;R Laufs;A D O'Brien

  • Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device.

    Carol O Tacket;Michael J Roy;Georg Widera;William F Swain

  • Progress in vaccines against typhoid fever.

    Myron M. Levine;Catterine Ferreccio;Robert E. Black;Carol O. Tacket

  • Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn.

    Carol O. Tacket;Marcela F. Pasetti;Robert Edelman;John A. Howard

  • Efficacy of Bovine Milk Immunoglobulin Concentrate in Preventing Illness after Shigella Flexneri Challenge

    Carol O. Tacket;Steven B. Binion;Eileen Bostwick;Genevieve Losonsky

  • Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in U.S. Volunteers

    Carol O. Tacket;Marcelo B. Sztein;Steven S. Wasserman;Genevieve Losonsky

  • Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.

    Carol O. Tacket;Mitchell B. Cohen;Steven S. Wasserman;Genevieve Losonsky

  • Safety of Live OralSalmonella typhiVaccine Strains with Deletions inhtrAandaroC aroDand Immune Response in Humans

    Carol O. Tacket;Marcelo B. Sztein;Genevieve A. Losonsky;Steven S. Wasserman

Frequent Co-Authors

Myron M. Levine
Myron M. Levine University of Maryland, Baltimore
Genevieve Losonsky
Genevieve Losonsky University of Maryland, Baltimore
Robert R. Edelman
Robert R. Edelman Northwestern University
James P. Nataro
James P. Nataro University of Virginia
Marcelo B. Sztein
Marcelo B. Sztein University of Maryland, Baltimore
Steven S. Wasserman
Steven S. Wasserman University of Virginia
Stanley J. Cryz
Stanley J. Cryz University of Massachusetts Chan Medical School
Marcela F. Pasetti
Marcela F. Pasetti University of Maryland, Baltimore
James B. Kaper
James B. Kaper University of Maryland, Baltimore
Gordon Dougan
Gordon Dougan University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare fields through online degrees can broaden career opportunities. Many professionals pursue nursing pathways that complement immunological expertise, such as Psychiatric Nurse Practitioner roles. Those looking for affordability may find a great starting point through cheap psych np programs, which offer cost-effective routes to advanced practice nursing.

Career growth in these areas is promising. Understanding the dnp salary landscape helps prospective students weigh their investment against potential earnings. Doctor of Nursing Practice degrees provide strong financial incentives, especially in states with high demand for advanced practice nurses.

For those already practicing as Family Nurse Practitioners, transitioning to specialized care can open new horizons. Guidance on how to make this shift is detailed in resources on fnp to acute care certification, allowing practitioners to target acute care settings that often engage immunology-related cases.

Additionally, accelerated options such as those highlighted in the accelerated fnp program category enable quicker entry into the nursing workforce while still covering critical knowledge areas. These programs balance speed and quality, supporting timely career advancement in immunology-adjacent fields.

Best Scientists Citing Carol O. Tacket